Boiron Toekomstige groei
Future criteriumcontroles 3/6
Boiron is forecast to grow earnings and revenue by 26.2% and 3.6% per annum respectively. EPS is expected to grow by 26.9% per annum. Return on equity is forecast to be 13.1% in 3 years.
Belangrijke informatie
26.2%
Groei van de winst
26.9%
Groei van de winst per aandeel
Pharmaceuticals winstgroei | 23.7% |
Inkomstengroei | 3.6% |
Toekomstig rendement op eigen vermogen | 13.1% |
Dekking van analisten | Low |
Laatst bijgewerkt | 07 Oct 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 528 | 40 | 55 | 81 | 1 |
12/31/2025 | 511 | 30 | 44 | 69 | 1 |
12/31/2024 | 493 | 20 | 56 | 58 | 1 |
6/30/2024 | 482 | 24 | 25 | 43 | N/A |
3/31/2024 | 487 | 30 | 26 | 44 | N/A |
12/31/2023 | 493 | 36 | 27 | 45 | N/A |
9/30/2023 | 505 | 42 | 23 | 40 | N/A |
6/30/2023 | 517 | 48 | 18 | 34 | N/A |
3/31/2023 | 526 | 46 | 29 | 46 | N/A |
12/31/2022 | 534 | 45 | 40 | 59 | N/A |
9/30/2022 | 528 | 48 | 44 | 64 | N/A |
6/30/2022 | 522 | 51 | 48 | 69 | N/A |
3/31/2022 | 489 | 40 | 31 | 51 | N/A |
12/31/2021 | 455 | 29 | 13 | 33 | N/A |
9/30/2021 | 453 | 23 | 13 | 34 | N/A |
6/30/2021 | 450 | 18 | 14 | 34 | N/A |
3/31/2021 | 482 | 22 | 31 | 51 | N/A |
12/31/2020 | 514 | 26 | 48 | 68 | N/A |
9/30/2020 | 534 | 33 | 52 | 76 | N/A |
6/30/2020 | 554 | 40 | 57 | 84 | N/A |
3/31/2020 | 556 | 40 | 35 | 67 | N/A |
12/31/2019 | 557 | 41 | 13 | 51 | N/A |
9/30/2019 | 569 | 38 | 19 | 59 | N/A |
6/30/2019 | 580 | 35 | 25 | 68 | N/A |
3/31/2019 | 592 | 46 | 31 | 76 | N/A |
12/31/2018 | 604 | 57 | 37 | 84 | N/A |
9/30/2018 | 609 | 66 | 43 | 92 | N/A |
6/30/2018 | 613 | 75 | 49 | 99 | N/A |
3/31/2018 | 615 | 77 | N/A | 102 | N/A |
12/31/2017 | 618 | 78 | N/A | 105 | N/A |
9/30/2017 | 616 | 77 | N/A | 104 | N/A |
6/30/2017 | 615 | 76 | N/A | 103 | N/A |
3/31/2017 | 615 | 77 | N/A | 106 | N/A |
12/31/2016 | 614 | 78 | N/A | 110 | N/A |
9/30/2016 | 616 | 78 | N/A | 103 | N/A |
6/30/2016 | 617 | 79 | N/A | 95 | N/A |
3/31/2016 | 612 | 76 | N/A | 99 | N/A |
12/31/2015 | 608 | 74 | N/A | 103 | N/A |
9/30/2015 | 616 | 83 | N/A | 114 | N/A |
6/30/2015 | 624 | 91 | N/A | 125 | N/A |
3/31/2015 | 617 | 90 | N/A | 111 | N/A |
12/31/2014 | 610 | 89 | N/A | 96 | N/A |
9/30/2014 | 607 | 83 | N/A | 91 | N/A |
6/30/2014 | 604 | 76 | N/A | 86 | N/A |
3/31/2014 | 611 | 79 | N/A | 96 | N/A |
12/31/2013 | 618 | 82 | N/A | 107 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: BOIR.F's forecast earnings growth (26.2% per year) is above the savings rate (2.5%).
Winst versus markt: BOIR.F's earnings (26.2% per year) are forecast to grow faster than the US market (15.9% per year).
Hoge groeiwinsten: BOIR.F's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: BOIR.F's revenue (3.6% per year) is forecast to grow slower than the US market (8.8% per year).
Hoge groei-inkomsten: BOIR.F's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: BOIR.F's Return on Equity is forecast to be low in 3 years time (13.1%).